Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus

NCT04216303 is registered in ClinicalTrials.gov with Methodist Health System as lead sponsor.

NCT NCT04216303
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04216303 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimal A1c Control in Post Liver or Combined Liver and Kidney Transplant Recipients Who Have Diabetes Mellitus
Lead sponsor
Methodist Health System
Phase
Observational
Overall status
Withdrawn
Start date
September 12, 2019
Completion date
August 19, 2021
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, kidney transplant failure, liver transplant; complications